NORTHAMPTON, MA / ACCESS Newswire / July 2, 2026 / By Ryan Rose<img height="0" src="https://app.accessnewswire.com/api/iframe/1185910/https://www.youtube.com/embed/dNJneHOYPPw" width="0"/></div></div></div><p><i>This blog was co-authored by Jennifer Mulhern, Vice President of AP Program Access, Col…
(14:45 GMT) Elevance Health Price Target Raised to $482.00/Share From $424.00 by Bernstein
Nvidia Corp. (NVDA, Financials) said it has partnered with AI cloud companies to deploy large-scale, multi-tenant AI factories through a revenue-sharing and credit-support model.Under the plan, cloud providers will sell services delivered through Nvidia DSX AI factories, which are designed to produ…
Integrated BioPharma amended its credit arrangements with PNC Bank, extending the maturity of its $4.0 million revolving credit facility to April 14, 2027, and establishing a new $250,000 Convertible Equipment Line of Credit for capital purchases. Concurrently, the company retired its previously ma…
CCC Intelligent Solutions Price Target Maintained With a $9.00/Share by Stifel
Ravi Thanawala was previously chief financial officer of Nike North America from June 2020 to July 2023. "American Eagle Names Ravi Thanawala CFO, Reaffirms 2026 Outlook" published at 4:37 p.m. ET on July 1 omitted the full location in the name.
Tango Therapeutics TNGX is moving into a decisive period as vopimetostat becomes the center of the investment case.The stock story now rests on MTAP-deleted cancers, 2026 clinical updates and the risks that come with a focused clinical-stage pipeline.Why TNGX Centers on PRMT5 BiologyTango uses synt…
IDAHO FALLS, Idaho, July 2, 2026 /PRNewswire/ -- Radnostix, Inc. (OTCQB: INIS) ("Radnostix" or the "Company"), a leader in radioisotope production and nuclear medicine solutions, today announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA®…
Vertex Pharmaceuticals VRTX announced that the FDA has approved its one-shot gene therapy, Casgevy (exagamglogene autotemcel), for the treatment of individuals aged two years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta th…
International Business Machines Corporation IBM has jumped 15.4% over the past three months, underperforming the industry’s growth of 127.3%, largely due to macroeconomic challenges and a sudden development in the artificial intelligence (AI) domain that threatens its core legacy businesses. The st…
Netskope NTSK offers a focused view of how cybersecurity demand is changing as enterprises adopt generative artificial intelligence, autonomous agents and cloud-delivered applications.The company is tying AI governance, secure access service edge and data protection into one platform. That combinat…
(14:40 GMT) Guardant Health Price Target Raised to $200.00/Share From $175.00 by Bernstein
(14:40 GMT) Mirum Pharmaceuticals Price Target Raised to $125.00/Share From $115.00 by JP Morgan
Affirm Holdings, Inc. AFRM has entered a new partnership with Bed Bath & Beyond, making its buy now, pay later (BNPL) solution available to eligible shoppers across the retailer's brands, including Bed Bath & Beyond, Overstock and buybuy BABY. Customers can choose to pay for purchases in biweekly o…
In a brief update, the US firm said it now expects to deliver between 65,000 and 70,000 vehicles this year, up from a prior forecast of between 62,000 and 67,000 units. Fuelling the increase was stronger-than-expected second-quarter demand, after 12,194 vehicles were delivered, well ahead of consen…
(14:39 GMT) Constellation Brands Price Target Cut to $165.00/Share From $169.00 by JP Morgan
(14:39 GMT) United Airlines Price Target Raised to $176.00/Share From $150.00 by TD Cowen
Netskope NTSK offers a mixed investment setup. The cybersecurity company has growth tied to cloud security, secure access service edge and AI-driven enterprise protection.The question is whether that promise is enough right now. Improving margins and raised guidance help the bull case, but cash flo…
(14:36 GMT) Charter Communications Price Target Cut to $125.00/Share From $185.00 by Goldman Sachs
(14:36 GMT) Skywest Price Target Raised to $115.00/Share From $98.00 by TD Cowen
